Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 3, 2026

Stock market today: Dow, S&P 500, and Nasdaq slide as oil rises amid war worries

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, and Nasdaq slide as oil rises amid war worries US stocks declined but came back from deeper losses for the second day in a row on Tuesday after Israel and US jets launched new strikes on Iran, as the widening conflict stoked worries about a drawn-out regional war…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • US could see a little high oil prices for a little while, but prices will drop lower than before after war ends

    80% confidence
  • Data sources show overall market share was at least flat, pointing to slightly softer customer demand during holiday quarter

    80% confidence
  • US military operation in Iran projected to last four to five weeks but capable of going far longer

    80% confidence
  • Trump administration's tariffs have been overwhelmingly borne by US consumers and businesses

    80% confidence
  • Target should stay in penalty box and is a 'prove it' stock

    80% confidence
  • Trump refused to rule out putting American boots on the ground in Iran

    80% confidence
  • Trump administration will soon roll out program to help mitigate rising energy costs

    80% confidence
  • Middle East war will affect near-term inflation outlook and increase economic uncertainty

    80% confidence
  • Until Target starts stacking positive quarters, don't buy the stock and favor Walmart or Costco on pullbacks

    80% confidence
  • Best Buy expects first quarter same-store sales to return to growth, rising 1%

    80% confidence
  • The hardest hits are yet to come from the US military in Iran campaign

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Stock market today: Dow, S&P 500, and Nasdaq slide as oil rises amid war worries — Source | Via News | ViaNews Market